134 related articles for article (PubMed ID: 24321352)
1. Risk factors and treatment outcomes of bloodstream infection caused by extended-spectrum cephalosporin-resistant Enterobacter species in adults with cancer.
Huh K; Kang CI; Kim J; Cho SY; Ha YE; Joo EJ; Chung DR; Lee NY; Peck KR; Song JH
Diagn Microbiol Infect Dis; 2014 Feb; 78(2):172-7. PubMed ID: 24321352
[TBL] [Abstract][Full Text] [Related]
2. Bloodstream infections caused by Enterobacter species: predictors of 30-day mortality rate and impact of broad-spectrum cephalosporin resistance on outcome.
Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Oh MD; Kim EC; Choe KW
Clin Infect Dis; 2004 Sep; 39(6):812-8. PubMed ID: 15472813
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics and predictors of mortality in patients with Enterobacter aerogenes bacteremia.
Chang EP; Chiang DH; Lin ML; Chen TL; Wang FD; Liu CY
J Microbiol Immunol Infect; 2009 Aug; 42(4):329-35. PubMed ID: 19949757
[TBL] [Abstract][Full Text] [Related]
4. Clinical epidemiology of ciprofloxacin resistance and its relationship to broad-spectrum cephalosporin resistance in bloodstream infections caused by Enterobacter species.
Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
Infect Control Hosp Epidemiol; 2005 Jan; 26(1):88-92. PubMed ID: 15693414
[TBL] [Abstract][Full Text] [Related]
5. Enterobacter bacteremia: Clinical features, risk factors for multiresistance and mortality in a Chinese University Hospital.
Ye Y; Li JB; Ye DQ; Jiang ZJ
Infection; 2006 Oct; 34(5):252-7. PubMed ID: 17033748
[TBL] [Abstract][Full Text] [Related]
6. Treatment outcomes in patients with third-generation cephalosporin-resistant Enterobacter bacteremia.
O'Neal CS; O'Neal HR; Daniels TL; Talbot TR
Scand J Infect Dis; 2012 Oct; 44(10):726-32. PubMed ID: 22681412
[TBL] [Abstract][Full Text] [Related]
7. Predictors of in-hospital mortality for bloodstream infections caused by Enterobacter species or Citrobacter freundii.
Deal EN; Micek ST; Ritchie DJ; Reichley RM; Dunne WM; Kollef MH
Pharmacotherapy; 2007 Feb; 27(2):191-9. PubMed ID: 17253909
[TBL] [Abstract][Full Text] [Related]
8. Impact of previous use of antibiotics on development of resistance to extended-spectrum cephalosporins in patients with enterobacter bacteremia.
Lee SO; Kim YS; Kim BN; Kim MN; Woo JH; Ryu J
Eur J Clin Microbiol Infect Dis; 2002 Aug; 21(8):577-81. PubMed ID: 12226687
[TBL] [Abstract][Full Text] [Related]
9. Bloodstream infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care hospital in New Zealand: risk factors and outcomes.
Freeman JT; McBride SJ; Nisbet MS; Gamble GD; Williamson DA; Taylor SL; Holland DJ
Int J Infect Dis; 2012 May; 16(5):e371-4. PubMed ID: 22401750
[TBL] [Abstract][Full Text] [Related]
10. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
Deal EN; Micek ST; Reichley RM; Ritchie DJ
Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
[TBL] [Abstract][Full Text] [Related]
11. The clinical relevance of Enterobacter infections.
Shlaes DM
Clin Ther; 1993; 15 Suppl A():21-8. PubMed ID: 8513457
[TBL] [Abstract][Full Text] [Related]
12. Effect of antimicrobial therapy on mortality in 377 episodes of Enterobacter spp. bacteraemia.
Marcos M; Iñurrieta A; Soriano A; MartÃnez JA; Almela M; Marco F; Mensa J
J Antimicrob Chemother; 2008 Aug; 62(2):397-403. PubMed ID: 18420813
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and risk factors for attributable mortality in Enterobacter cloacae bacteremia.
Lin YC; Chen TL; Ju HL; Chen HS; Wang FD; Yu KW; Liu CY
J Microbiol Immunol Infect; 2006 Feb; 39(1):67-72. PubMed ID: 16440126
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the clinical significance of production of extended-spectrum beta-lactamases (ESBL) by Enterobacteriaceae.
Henshke-Bar-Meir R; Yinnon AM; Rudensky B; Attias D; Schlesinger Y; Raveh D
Infection; 2006 Apr; 34(2):66-74. PubMed ID: 16703295
[TBL] [Abstract][Full Text] [Related]
15. Enterobacter meningitis: organism susceptibilities, antimicrobial therapy and related outcomes.
Foster DR; Rhoney DH
Surg Neurol; 2005 Jun; 63(6):533-7; discussion 537. PubMed ID: 15936376
[TBL] [Abstract][Full Text] [Related]
16. Beta-lactam-resistant Enterobacter bacteremia in febrile neutropenic patients receiving monotherapy.
Johnson MP; Ramphal R
J Infect Dis; 1990 Oct; 162(4):981-3. PubMed ID: 2205658
[TBL] [Abstract][Full Text] [Related]
17. Bloodstream infections caused by qnr-positive Enterobacteriaceae: clinical and microbiologic characteristics and outcomes.
Chong YP; Choi SH; Kim ES; Song EH; Lee EJ; Park KH; Cho OH; Kim SH; Lee SO; Kim MN; Jeong JY; Woo JH; Kim YS
Diagn Microbiol Infect Dis; 2010 May; 67(1):70-7. PubMed ID: 20227228
[TBL] [Abstract][Full Text] [Related]
18. Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment.
Tumbarello M; Sanguinetti M; Montuori E; Trecarichi EM; Posteraro B; Fiori B; Citton R; D'Inzeo T; Fadda G; Cauda R; Spanu T
Antimicrob Agents Chemother; 2007 Jun; 51(6):1987-94. PubMed ID: 17387156
[TBL] [Abstract][Full Text] [Related]
19. Outcome of antibiotic therapy for third-generation cephalosporin-resistant Gram-negative bacteraemia: an analysis of 249 cases caused by Citrobacter, Enterobacter and Serratia species.
Kim BN; Lee SO; Choi SH; Kim NJ; Woo JH; Ryu J; Kim YS
Int J Antimicrob Agents; 2003 Aug; 22(2):106-11. PubMed ID: 12927949
[TBL] [Abstract][Full Text] [Related]
20. Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporins.
de Kraker ME; Wolkewitz M; Davey PG; Koller W; Berger J; Nagler J; Icket C; Kalenic S; Horvatic J; Seifert H; Kaasch A; Paniara O; Argyropoulou A; Bompola M; Smyth E; Skally M; Raglio A; Dumpis U; Melbarde Kelmere A; Borg M; Xuereb D; Ghita MC; Noble M; Kolman J; Grabljevec S; Turner D; Lansbury L; Grundmann H
J Antimicrob Chemother; 2011 Feb; 66(2):398-407. PubMed ID: 21106563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
